Daihan Pharmaceutical (Korea) Price Prediction
| 023910 Stock | KRW 26,450 250.00 0.95% |
Oversold Vs Overbought
24
Oversold | Overbought |
Using Daihan Pharmaceutical hype-based prediction, you can estimate the value of Daihan Pharmaceutical CoLtd from the perspective of Daihan Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Daihan Pharmaceutical to buy its stock at a price that has no basis in reality. In that case, they are not buying Daihan because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Daihan Pharmaceutical after-hype prediction price | KRW 26450.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Daihan |
Daihan Pharmaceutical After-Hype Price Prediction Density Analysis
As far as predicting the price of Daihan Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Daihan Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Daihan Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Daihan Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Daihan Pharmaceutical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Daihan Pharmaceutical's historical news coverage. Daihan Pharmaceutical's after-hype downside and upside margins for the prediction period are 26,449 and 26,451, respectively. We have considered Daihan Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Daihan Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Daihan Pharmaceutical is based on 3 months time horizon.
Daihan Pharmaceutical Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Daihan Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Daihan Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Daihan Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.01 | 0.96 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
26,450 | 26,450 | 0.00 |
|
Daihan Pharmaceutical Hype Timeline
Daihan Pharmaceutical is presently traded for 26,450on KOSDAQ of Korea. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Daihan is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.01%. %. The volatility of related hype on Daihan Pharmaceutical is about 0.0%, with the expected price after the next announcement by competition of 26,450. About 35.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Daihan Pharmaceutical had 10:1 split on the 29th of April 2002. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days. Check out Daihan Pharmaceutical Basic Forecasting Models to cross-verify your projections.Daihan Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Daihan Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Daihan Pharmaceutical's future price movements. Getting to know how Daihan Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Daihan Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 102940 | Kolon Life Science | 0.00 | 0 per month | 0.00 | (0.24) | 3.11 | (3.10) | 8.97 | |
| 074430 | Aminologics CoLtd | 0.00 | 0 per month | 0.00 | (0.24) | 2.76 | (3.97) | 13.89 | |
| 330350 | Withuspharmaceutical CoLtd | 0.00 | 0 per month | 0.00 | (0.21) | 3.33 | (3.93) | 9.83 | |
| 106190 | High Tech Pharm | 0.00 | 0 per month | 0.00 | (0.13) | 4.35 | (4.91) | 11.21 |
Daihan Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Daihan price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Daihan using various technical indicators. When you analyze Daihan charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Daihan Pharmaceutical Predictive Indicators
The successful prediction of Daihan Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Daihan Pharmaceutical CoLtd, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Daihan Pharmaceutical based on analysis of Daihan Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Daihan Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Daihan Pharmaceutical's related companies.
Story Coverage note for Daihan Pharmaceutical
The number of cover stories for Daihan Pharmaceutical depends on current market conditions and Daihan Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Daihan Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Daihan Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Daihan Pharmaceutical Short Properties
Daihan Pharmaceutical's future price predictability will typically decrease when Daihan Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Daihan Pharmaceutical CoLtd often depends not only on the future outlook of the potential Daihan Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Daihan Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6 M | |
| Cash And Short Term Investments | 96.4 B |
Complementary Tools for Daihan Stock analysis
When running Daihan Pharmaceutical's price analysis, check to measure Daihan Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daihan Pharmaceutical is operating at the current time. Most of Daihan Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Daihan Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daihan Pharmaceutical's price. Additionally, you may evaluate how the addition of Daihan Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |